1. Home
  2. WEYS vs FHTX Comparison

WEYS vs FHTX Comparison

Compare WEYS & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$37.92

Market Cap

331.9M

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$4.84

Market Cap

323.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEYS
FHTX
Founded
1906
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.9M
323.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
WEYS
FHTX
Price
$37.92
$4.84
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$11.50
AVG Volume (30 Days)
15.9K
402.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
3.24%
N/A
EPS Growth
N/A
25.32
EPS
0.64
N/A
Revenue
$276,169,000.00
$30,909,000.00
Revenue This Year
N/A
$8.89
Revenue Next Year
N/A
$20.13
P/E Ratio
$59.30
N/A
Revenue Growth
N/A
36.75
52 Week Low
$27.25
$3.27
52 Week High
$40.41
$6.95

Technical Indicators

Market Signals
Indicator
WEYS
FHTX
Relative Strength Index (RSI) 50.69 44.84
Support Level $30.78 $4.37
Resistance Level $40.20 $5.70
Average True Range (ATR) 1.26 0.43
MACD -0.20 -0.11
Stochastic Oscillator 42.31 0.00

Price Performance

Historical Comparison
WEYS
FHTX

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: